Previous Close | 12.80 |
Open | 12.70 |
Bid | 12.40 x 150000 |
Ask | 12.80 x 150000 |
Day's Range | 12.50 - 12.70 |
52 Week Range | 10.80 - 18.30 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
FT. MYERS, Fla., May 28, 2024--NeoGenomics will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at ASCO 2024 in Chicago (booth #31093).
FORT MYERS, Fla., April 30, 2024--NeoGenomics, Inc. announced its first-quarter results for the period ended March 31, 2024.
FT. MYERS, Fla., April 18, 2024--NeoGenomics, Inc., announced two promotions within its senior leadership team, effective immediately.